In conclusion, our comprehensive evaluation of BRCA1/BRCA2 in families with criteria for hereditary breast cancer found three known BRCA1/BRCA2 mutations and BRCA1 c.4647_4648dupAA as a novel pathogenic. The gene discussed is BRCA1; the disease is breast cancer.